Literature DB >> 20302566

Update information on drug metabolism systems--2009, part II: summary of information on the effects of diseases and environmental factors on human cytochrome P450 (CYP) enzymes and transporters.

S Rendic1, F P Guengerich.   

Abstract

The present paper is an update of the data on the effects of diseases and environmental factors on the expression and/or activity of human cytochrome P450 (CYP) enzymes and transporters. The data are presented in tabular form (Tables 1 and 2) and are a continuation of previously published summaries on the effects of drugs and other chemicals on CYP enzymes (Rendic, S.; Di Carlo, F. Drug Metab. Rev., 1997, 29(1-2), 413-580., Rendic, S. Drug Metab. Rev., 2002, 34(1-2), 83-448.). The collected information presented here is as stated by the cited author(s), and in cases when several references are cited the latest published information is included. Inconsistent results and conclusions obtained by different authors are highlighted, followed by discussion of the major findings. The searchable database is available as an Excel file, for information about file availability contact the corresponding author.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20302566      PMCID: PMC4167379          DOI: 10.2174/138920010791110917

Source DB:  PubMed          Journal:  Curr Drug Metab        ISSN: 1389-2002            Impact factor:   3.731


  429 in total

1.  CYP1A1 and CYP1B1 expressions in medulloblastoma cells are AhR-independent and have no direct link with resveratrol-induced differentiation and apoptosis.

Authors:  Mo-Li Wu; Hong Li; Da-Chang Wu; Xiao-Wei Wang; Xiao-Yan Chen; Qing-You Kong; Jing-Xin Ma; Ying Gao; Jia Liu
Journal:  Neurosci Lett       Date:  2005 Aug 12-19       Impact factor: 3.046

2.  The expression of cytochrome P450 enzymes in human breast tumours and normal breast tissue.

Authors:  M Iscan; T Klaavuniemi; T Coban; N Kapucuoglu; O Pelkonen; H Raunio
Journal:  Breast Cancer Res Treat       Date:  2001-11       Impact factor: 4.872

3.  Cytochrome P450 expression in oesophageal cancer.

Authors:  G I Murray; D Shaw; R J Weaver; J A McKay; S W Ewen; W T Melvin; M D Burke
Journal:  Gut       Date:  1994-05       Impact factor: 23.059

4.  Expression of pulmonary cytochrome P4501A1 and carcinogen DNA adduct formation in high risk subjects for tobacco-related lung cancer.

Authors:  H Bartsch; M Castegnaro; M Rojas; A M Camus; K Alexandrov; M Lang
Journal:  Toxicol Lett       Date:  1992-12       Impact factor: 4.372

5.  Regulation of drug-metabolizing enzymes and transporters in infection, inflammation, and cancer.

Authors:  Edward T Morgan; Kerry B Goralski; Micheline Piquette-Miller; Kenneth W Renton; Graham R Robertson; Madhusudana R Chaluvadi; Kellie A Charles; Stephen J Clarke; Marina Kacevska; Christopher Liddle; Terrilyn A Richardson; Rohini Sharma; Christopher J Sinal
Journal:  Drug Metab Dispos       Date:  2008-02       Impact factor: 3.922

6.  Expression of multidrug-resistance-related proteins P-glycoprotein, glutathione-S-transferases, topoisomerase-II and lung resistance protein in primary gastric cardiac adenocarcinoma.

Authors:  Hongcan Shi; Dan Lu; Yusheng Shu; Weiping Shi; Shichun Lu; Kang Wang
Journal:  Cancer Invest       Date:  2008-05       Impact factor: 2.176

7.  Expression of CYP1A1 and CYP1B1 in human endothelial cells: regulation by fluid shear stress.

Authors:  Daniel E Conway; Yumiko Sakurai; Daiana Weiss; J David Vega; W Robert Taylor; Hanjoong Jo; Suzanne G Eskin; Craig B Marcus; Larry V McIntire
Journal:  Cardiovasc Res       Date:  2009-01-06       Impact factor: 10.787

Review 8.  Pharmacogenomics of MRP transporters (ABCC1-5) and BCRP (ABCG2).

Authors:  Ulrike Gradhand; Richard B Kim
Journal:  Drug Metab Rev       Date:  2008       Impact factor: 4.518

9.  Diagnostic utility of GLUT1 in the differential diagnosis of liver carcinomas.

Authors:  Mee Sook Roh; Jin Sook Jeong; Young Hoon Kim; Min Chan Kim; Sook Hee Hong
Journal:  Hepatogastroenterology       Date:  2004 Sep-Oct

10.  Expression of LRP and MDR1 in locally advanced breast cancer predicts axillary node invasion at the time of rescue mastectomy after induction chemotherapy.

Authors:  J Schneider; S Gonzalez-Roces; M Pollán; R Lucas; A Tejerina; M Martin; A Alba
Journal:  Breast Cancer Res       Date:  2001-02-01       Impact factor: 6.466

View more
  37 in total

1.  Pharmacokinetics and tolerability of single and multiple doses of ticagrelor in healthy Chinese subjects: an open-label, sequential, two-cohort, single-centre study.

Authors:  Haiyan Li; Kathleen Butler; Li Yang; Zhenghua Yang; Renli Teng
Journal:  Clin Drug Investig       Date:  2012-02-01       Impact factor: 2.859

Review 2.  Contributions of human enzymes in carcinogen metabolism.

Authors:  Slobodan Rendic; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2012-05-10       Impact factor: 3.739

Review 3.  Human Family 1-4 cytochrome P450 enzymes involved in the metabolic activation of xenobiotic and physiological chemicals: an update.

Authors:  Slobodan P Rendic; F Peter Guengerich
Journal:  Arch Toxicol       Date:  2021-01-18       Impact factor: 5.153

4.  In vivo drug interactions of the teratogen thalidomide with midazolam: heterotropic cooperativity of human cytochrome P450 in humanized TK-NOG mice.

Authors:  Hiroshi Yamazaki; Hiroshi Suemizu; Norie Murayama; Masahiro Utoh; Norio Shibata; Masato Nakamura; F Peter Guengerich
Journal:  Chem Res Toxicol       Date:  2013-03-01       Impact factor: 3.739

5.  Nonadditivity in human microsomal drug metabolism revealed in a study with coumarin 152, a polyspecific cytochrome P450 substrate.

Authors:  Bikash Dangi; Nadezhda Y Davydova; Nikita E Vavilov; Victor G Zgoda; Dmitri R Davydov
Journal:  Xenobiotica       Date:  2020-07-26       Impact factor: 1.908

6.  Characterization of polybrominated diphenyl ether toxicity in Wistar Han rats and use of liver microarray data for predicting disease susceptibilities.

Authors:  June K Dunnick; A Brix; H Cunny; M Vallant; K R Shockley
Journal:  Toxicol Pathol       Date:  2012       Impact factor: 1.902

Review 7.  Development and Uses of Offline and Web-Searchable Metabolism Databases - The Case of Benzo[a]pyrene.

Authors:  Slobodan P Rendic; Frederick P Guengerich
Journal:  Curr Drug Metab       Date:  2018       Impact factor: 3.731

8.  Use of Phenoxyaniline Analogues To Generate Biochemical Insights into the Interactio n of Polybrominated Diphenyl Ether with CYP2B Enzymes.

Authors:  Chao Chen; Jingbao Liu; James R Halpert; P Ross Wilderman
Journal:  Biochemistry       Date:  2017-12-19       Impact factor: 3.162

9.  Phenoconversion of CYP2D6 by inhibitors modifies aripiprazole exposure.

Authors:  Ádám Kiss; Ádám Menus; Katalin Tóth; Máté Déri; Dávid Sirok; Evelyn Gabri; Ales Belic; Gábor Csukly; István Bitter; Katalin Monostory
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2019-01-02       Impact factor: 5.270

10.  CYP2J2 overexpression increases EETs and protects against angiotensin II-induced abdominal aortic aneurysm in mice.

Authors:  Zhejun Cai; Gang Zhao; Jiangtao Yan; Wanjun Liu; Wenjing Feng; Ben Ma; Lei Yang; Jian-an Wang; Ling Tu; Dao Wen Wang
Journal:  J Lipid Res       Date:  2013-02-26       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.